Cardiovascular autonomic neuropathy is associated with SLEDAI in patients with systemic lupus erythematosus

Simin Guo1, Yujiao Wang1, Lingyun Sun2

  • 1Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, No 321 Zhongshan Road, Nanjing, 210008, China.

Clinical Rheumatology
|January 22, 2025
PubMed

Insights

Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) is associated with cardiovascular autonomic neuropathy (CAN) in SLE patients. Higher SLEDAI scores indicate increased risk and progression of CAN, offering a valuable clinical indicator.

Area of Science:

  • Rheumatology
  • Cardiology
  • Neurology

Background:

  • Cardiovascular autonomic neuropathy (CAN) is a severe complication of systemic lupus erythematosus (SLE).
  • CAN's potential link to SLE disease activity requires further investigation.
  • Understanding this association can improve patient outcomes and management.

Purpose of the Study:

  • To explore the association between SLEDAI and CAN in SLE patients.
  • To evaluate the diagnostic value of SLEDAI for CAN.
  • To identify SLEDAI as a potential risk factor for CAN development.

Main Methods:

  • 144 SLE patients were assessed using SLEDAI and cardiovascular reflex tests (CARTs).
  • Patients were categorized into non-CAN, early-CAN, and diagnosed-CAN groups.
  • Statistical analysis (SPSS 26.0) examined the relationship between CARTs and SLEDAI.

Main Results:

  • Significant differences in SLEDAI were observed across CAN severity groups.
  • Increasing SLEDAI scores correlated with higher CARTs scores and parameter scores, even after adjustments.
  • SLEDAI was identified as an independent risk factor for CAN (OR=1.227, P<0.001).

Conclusions:

  • CARTs and SLEDAI are significantly correlated, with SLEDAI being a dependable indicator for CAN onset and progression.
  • SLEDAI is an independent risk factor for CAN in SLE patients.
  • This research provides a convenient method for clinical evaluation of CAN in SLE patients.
Abstract